Skip to content

Author

K. Faierstein

7 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Transmitral mean pressure gradient after transcatheter aortic valve replacement and late mortality

Risk stratification after transcatheter aortic valve replacement (TAVR) focuses largely on aortic valve performance and baseline clinical characteristics. The prognostic relevance of residual transmitral haemodynamics after TAVR is uncertain. To assess whether post-TAVR transmitral mean pressure gradient (...

I. Cohen, D. Moshkovitz, A. Ash et al. · 0 citations
Review Open access Oct 2026

Prognostic power of artificial intelligence based estimation of left ventricular ejection fraction in standard and point-of-care echocardiography

Artificial intelligence (AI)-based left ventricular ejection fraction (LVEF) estimation compares reasonably well with conventional readings. We assessed its prognostic value in the standard transthoracic echocardiography (TTE) and point-of-care-ultrasound (POCUS) settings. AI-based LVEF estimation was retr...

K. Faierstein, R. Loutati, M. Fiman et al. · 0 citations
Open access Oct 2026

Development and external validation of a novel echocardiography-based AI model for predicting aortic stenosis progression

Aortic stenosis (AS) is the most common valvular heart disease in older adults and requires timely identification of patients who need intervention. Nevertheless, current surveillance strategies rely on fixed follow-up intervals that do not adequately reflect the highly variable rate of disease progression among...

K. Faierstein, E. Itelman, T. Caller et al. · 0 citations
Open access Oct 2026

Sex-specific impact of chronic kidney disease on mortality and dialysis in heart failure with metabolic syndrome

Cardiovascular-kidney-metabolic (CKM) syndrome is a systemic disorder defined by the overlapping burden of heart failure (HF), chronic kidney disease (CKD), diabetes, and obesity. Although sex differences in cardiovascular disease are increasingly recognized, sex-specific patterns of mortality and renal progressi...

D. Hochstein, R. Loutati, V. Copeland et al. · 0 citations
Open access Oct 2026

Chronic kidney disease in metabolic syndrome and heart failure: elevated risk, underutilized therapies, and missed opportunities for improved outcomes

In patients with late-stage metabolic syndrome, CKD identifies a high-risk subgroup with a graded increase in mortality and dialysis risk compared with eGFR ≥60, and the heightened dialysis risk remained pronounced after accounting for competing death.

D. Hochstein, R. Loutati, V. Copeland et al. · 0 citations
Open access Aug 2026

Determinants and prognostic value of atrial and ventricular ectopic burden in adults without structural heart disease

In asymptomatic adults without structural heart disease, the clinical determinants and long-term prognostic trajectories of ectopy exhibit a profound chamber-specific divergence and stands out as a powerful, independent marker of intrinsic electrical vulnerability and long-term cardiovascular risk.

A. Moses, Rotem Givoli Vilensky, N. Makmal et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.